Consumer Perspectives on Quality of Care in the Treatment of Schizophrenia

Abstract

Guidelines and best practices represent advances in the promotion of quality care in the treatment of schizophrenia. These efforts have been primarily developed by clinicians and academic researchers, and appropriately focus on psychopharmacological treatments. However, including other perspectives in the guideline development process may expand what is considered to be quality care. This study examines the opinions of forty individuals diagnosed with schizophrenia as to what constitutes quality treatment. Results from a thematic analysis indicate wide agreement on the importance of good psychopharmacology and case management, but respondents also emphasized the importance of a good interpersonal process, and the need for psychosocial rehabilitation supports. Current practice guideline efforts should consider including interpersonal process standards that have been demonstrated to enhance therapeutic relationships and ultimately clinical outcomes, and enhance their emphasis on psychosocial rehabilitation supports.